Amikacin has been shown to antagonize the bactericidal effect of penicillin against strains of Streptococcus faecalis which produce aminoglycoside 3'-phosphotransferase. The mechanism by which this phenomenon occurs was studied with an enzyme-producing strain (8436) and an enzyme-negative strain (8436c) derived by curing the former with novobiocin. Combinations of amikacin with 3-lactam antibiotics were antagonistic against strain 8436 but synergistic against strain 8436c. Against strain 8436 penicillin-amikacin combinations resulted in levels of killing comparable to those seen with high concentrations of penicillin (500 ,ug/ml), which were less bactericidal than lower concentrations of penicillin. No antagonism was observed between amikacin and non-l-lactam cell wall-active drugs or between penicillin and kanamycin or neomycin, both of which are substrates for the enzyme. At concentrations near the MIC, amikacin was bactericidal against strain 8436c but bacteriostatic against strain 8436 (MIC, 250 ,ug/ml; MBC, 2,000 ,Ig/ml). Neither penicillin nor phosphorylated amikacin affected the inhibition of ribosomal protein synthesis by amikacin in a cell-free system. Although antagonism of killing by amikacin in enzyme-positive strains was specific for combinations which included t-lactam antibiotics, amikacin did not influence the binding of [3HJpenicillin to penicillin-binding proteins in isolated bacterial cell membranes or in intact cells and did not detectably affect the autolytic system of cells exposed to penicillin. Antagonism of 13-lactam activity by a bacteriostatic effect of amikacin against the enzyme-producing strain is the most likely explanation for this phenomenon.
cocci are substantially higher than for other streptococci, and enterococci exhibit tolerance to the usual bactericidal effect of cell wall-active agents (9) . It has been generally thought that combinations of penicillin with an aminoglycoside demonstrate bactericidal synergism against strains of S. faecalis (15, 17) unless the organisms possess high-level resistance, (MIC, 500 to 2,000 ,ug/ml) to the aminoglycoside (7, 18) . However, Calderwood et al. (1) showed that, in S. faecalis strains which produce aminoglycoside 3'-phosphotransferase [APH(3')], amikacin may actually antagonize the bactericidal effect of penicillin, even in the absence of high-level resistance to the aminoglycoside. The purpose of this work was to further investigate the mechanisms of this antagonism by studying the influence of penicillin-amikacin combinations on ribosomal protein synthesis, the binding of radiolabeled penicillin to penicillin-binding proteins (PBPs) of isolated bacterial membranes and intact cells, and antibiotic-induced cell lysis.
(This work was presented in part at the 23rd Interscience Conference on Antimicrobial Agents and Chemotherapy [C. Thauvin, G. M. Eliopoulos, and R. C. Moellering termined in dextrose phosphate broth (GIBCO Diagnostics, Madison, Wis.) by a standard broth dilution technique with an inoculum of 105 to 106 CFU/ml prepared by appropriate dilutions of overnight cultures. The lowest concentration of antibiotic which prevented visible growth after 24 h of incubation was defined as the MIC. Samples of 0.01 ml from each clear tube were streaked onto blood agar plates, and the MBCs were determined at the 99.9% killing level.
Time-kill curve studies. Killing curves were performed in dextrose phosphate broth with an inoculum of 108 CFU/ml and penicillin concentrations ranging from 5 to 500 ,ug/ml. Studies of antibiotic synergism were performed by time-kill methods described previously (13) . Two inocula, 105 and 108 CFU/ml, were used. The concentration of aminoglycoside used (20 ,ug/ml) was below the MIC for the strains tested and did not interfere with their growth. Synergism was defined as an increase in killing of 100-fold or greater at 24 h by a drug combination as compared with killing produced by the most effective drug alone. Antagonism was defined as a decrease in killing of 10-fold or greater at 24 h by the combination as compared with the most effective drug alone.
Quantitative phosphorylation of amikacin. Quantitative phosphorylation of amikacin was performed as described by Krogstad et al (8) . S. faecalis 8436 was grown in dextrose phosphate broth at 37°C for 6 h. Cells were harvested by centrifugation at 10,000 x g and washed in potassium phosphate buffer (10 mM, pH 7.0), and the pellet was resuspended in 5 ml of TMN buffer (10 mM magnesium acetate, 20 mM Tris, 70 mM NH4CI, 1 mM dithiothreitol, pH 7.6) and frozen at -70°C until use. On the day of the experiment, cells were thawed and ultrasonically disrupted. Intact cells and large particles were removed by centrifugation at 10,000 x g for 30 min. The supernatant was used as a crude enzyme preparation to phosphorylate amikacin. To a 50-ml tube were added Tris buffer (0.2 ml, 1.0 M, pH 8.0), M9gC2 (0.04 ml, 1.0 M), dithiothreitol (0.03 ml, 0.5 M), amikacin (0.5 ml, 10-mg/ml solution), distilled water (2.03 ml), cell sonic extract (2.0 ml), and ATP (0.1 ml; 0.2 M ATP in 1.0 M Tris buffer, pH 7.6). This mixture was incubated for 36 h at 37°C in a water bath with slow shaking. Additional ATP (0.1 ml, 0.2 M) was added after 6, 12, 20, and 27 h of incubation. Any remaining bacterial cells and other debris were removed by ultracentrifugation at 100,000 x g for 120 min at 4°C. The amount of residual amikacin was determined by a microbiological assay with Staphylococcus epidermidis as the indicator organism. Before use in experiments in which penicillin and phosphorylated amikacin were combined, the crude preparation of phosphorylated amikacin was sterilized by passage through a membrane filter (pore size, 0.45 ,um; Millipore Corp., Bedford, Mass.).
Ribosomal protein synthesis. The effect of amikacin or phosphorylated amikacin or both on ribosomal protein synthesis was examined in S. faecalis El, a strain which lacks aminoglycoside-modifying enzymes and which has been used in previous studies of enterococcal ribosomes (18 Antibiotic-induced cell lysis. Studies of antibiotic-induced cell lysis were carried out by the method of Storch and Krogstad (16) . Cell cultures in the log phase of growth (approximately 2 x 108 CFU/ml) were exposed to penicillin (5 ,ug/ml), to a combination of penicillin with amikacin (20 ,ug/ml), or to no antibiotic. Cell lysis was determined by measuring the decrease in optical absorbance at 675 nm over time with a Beckman DU-5 spectrophotometer. The validity of this method for detecting lysis of enterococci was ascertained with S. faecalis test strains 1345 and 1360, kindly provided by D. Krogstad, Washington University, St. Louis, Mo. RESULTS Susceptibility studies. The susceptibilities of S. faecalis strains 8436 and 8436c to penicillin were identical (MIC and MBC, 2 pgIml). Amikacin was bactericidal at the MIC (250 ,ug/ml) for S. faecalis 8436c. Against the APH(3')-producing strain (8436), the amikacin MIC was 250 ,ug/ml and the MBC was 2,000 pg/ml.
Quantitative phosphorylation of amikacin. Measurement of residual amikacin after the phosphorylation procedure indicated a 98.75% conversion of amikacin to phosphorylated amikacin.
Synergism studies. Against the APH(3')-producing strain, the combination of penicillin (6 pLg/ml) with amikacin (20 ,ug/ml) resulted in an antagonistic effect, with a 50-fold decrease in killing at 24 h compared with that of penicillin alone (Fig. 1A) . Penicillin and amikacin were synergistic against S. faecalis 8436c, which lacks APH(3') (Fig. 1B) . When penicillin was combined with phosphorylated amikacin (20 pug/ml), neither synergism nor antagonism was observed against S. faecalis 8436c (data not shown). Interactions betWeen amikacin and other cell wall-active antibiotics against S. faecalis strains 8436 and 8436c are shown in Table 1 . Against the APH(3')-negative strain, each of the combinations acted synergistically or tended to be synergistic. Against the APH(3')-producing strain, antagonism was noted only with combinations which included a P-lactam, whereas vancomycin, cycloserine, and bacitracin used in combination with amikacin demonstrated an indifferent effect. Neither kanamycin nor neomycin, which are also substrates of enterococcal APH(3'), antagonized the bactericidal effect of penicillin against S. faecalis 8436 ( Table 2) . The antagonistic effect of penicillin-amikacin combinations was examined over a wide range of concentration ratios (Table 3) . Antagonism was most striking when low concentrations of penicillin were used.
Time-kill studies. In time-kill studies, low concentrations of penicillin (5 to 10 ,ug/ml) were considerably more bactericidal than high concentrations (50 to 500 ,ug/ml) (Fig. 2) . The magnitude of killing observed when amikacin was added to a low concentration of penicillin (5 ,g/ml) approached but never fell below the magnitude of killing produced by high concentrations of penicillin.
Ribosomal protein synthesis. Amikacin at low concentrations inhibited polyphenylalanine synthesis (Fig. 3) . Addition of penicillin (10 jig/Ml) or phosphorylated amikacin (10 ,glml) or both did not affect the inhibitory action of amikacin. Penicillin alone at concentrations of up to 500 p.g/ml had no effect on polypeptide synthesis in this cell-free system. PBP studies. Binding of [3H]penicillin to isolated bacterial cell membranes is shown in Fig. 4 . Five PBPs were identified in both strains and labeled 1 through 5. Apparent molecular 6) and 8436c (lanes 7 through 12) .
Before being labeled with penicillin, cells were preincubated for 1 h with amikacin at 62 jig/ml (lanes 2 and 8) or 250 ,ug/ml (lanes 3 and 9) or for 2 h with amikacin at 16 ,ug/ml (lanes 4 and 10) , 62 u.g/ml (lanes 5 and 11), or 250 ,ug/ml (lanes 6 and 12). weights were 115,000, 92,000, and 43,000 for PBPs 1, 2, and 5, respectively, and 80,000 for the PBP 3-4 complex. Over a wide range of concentrations, the binding of [3H]penicillin to membranes of strains 8436 and 8436c gave identical patterns. Figure 5 shows the results obtained with intact cells of strains 8436 and 8436c. The PBP 3-4 complex observed in membrane preparation appeared as three bands in intact cells, and similarly, PBP 5 appeared as two bands, PBPs 5a and 5b. Although preincubation with amikacin resulted in some differences in the relative intensities of PBP bands 5a and 5b as compared with PBP bands in cells not exposed to amikacin, these differences were identical for strains 8436 and 8436c and therefore cannot account for differences in antagonism.
Antibiotic-induced cell lysis. As determined by the method of Storch and Krogstad (16) , the degree of cell lysis resulting from exposure to penicillin alone and that resulting from exposure to the combination of penicillin with amikacin differed by less than 10o for both strains 8436 and 8436c. DISCUSSION
Combinations of penicillin with an aminoglycoside usually demonstrate bactericidal synergism against strains of S. faecalis which do not possess high-level resistance to the aminoglycoside (15) . Such high-level resistance may be conferred by either production of aminoglycoside-modifying enzymes (8) or, as in the case of streptomycin, ribosomal resistance to the drug (3) . However, actual antagonism of the bactericidal effect of penicillin by amikacin in strains which phosphorylate amikacin but which are not highly resistant to this aminoglycoside (1) The fact that amikacin was bactericidal at the MIC of the APH(3')-negative strain but only bacteriostatic against the APH(3')-producing strain suggests that the observed antagonism of penicillin-amikacin combinations against the enzyme-producing strain is due to the bacteriostatic activity of amikacin in this setting. That neither kanamycin nor neomycin, which are also substrates of enterococcal APH(3'), antagonized the activity of penicillin supports this hypothesis, since neither drug exerted an inhibitory effect against the APH(3')-producing strain at the highest concentration tested (MIC, >32,000 ,ug/ml).
Because the addition of phosphorylated amikacin over a range of concentrations 1-to 100-fold those of amikacin had no effect on the inhibition of ribosomal protein synthesis by amikacin in the cell-free system, the mechanisms accounting for the bacteriostatic effect of amikacin against the APH(3')-producing strain remain uncertain. warranted.
